These findings reflected a mechanism of escape of DLBCL cells from chemotherapy and suggested that FOXP1-GINS1 may be a possible therapeutic target to enhance the effect of chemotherapy. This evidence concerns the gene GINS1 and diffuse large B-cell lymphoma.